Alzheimer's disease & dementia

Brain receptor cell could be new target for Alzheimer's

Blocking a key receptor in brain cells that is used by oxygen free radicals could play a major role in neutralizing the biological consequences of Alzheimer's disease, according to researchers at Temple University.

Inflammatory disorders

Chronic inflammation accelerates ageing

(Medical Xpress)—Inflammation could be a key factor in the ageing process academics at Newcastle University have found, and the discovery could help scientists identify new ways of delaying ageing.

Medical research

Battle of the bulge occurs in the liver

(Medical Xpress)—An international team of scientists led by Monash University researchers has shown how free radicals contribute to type 2 diabetes, obesity and fatty liver disease.

Autism spectrum disorders

Study confirms mitochondrial deficits in children with autism

Children with autism experience deficits in a type of immune cell that protects the body from infection. Called granulocytes, the cells exhibit one-third the capacity to fight infection and protect the body from invasion ...

Medical research

Biomarkers help to gauge tissue injury causes

(Medical Xpress)—Lipid biomarkers of oxidative stress can be measured to confirm the cause of tissue injury in several medical conditions including stroke and pre-eclampsia.

Ophthalmology

Saving the sight of premature babies

Scientists at Australia's Vision Centre have made an important breakthrough that could save the sight of premature babies.

Medical research

'WAVE1' identified as key protein in sepsis

Sepsis is a feared complication in bacterial infections. Despite treatment with antibiotics this uncontrolled systemic inflammation is linked to a very high mortality rate because there is no treatment that could bring the ...

Oncology & Cancer

New drug protects against side effects of chemotherapy

A drug developed at Linköping University in Sweden protects against the side effects of cancer treatments while strengthening the effects on the tumour. An international drug evaluation is now starting up on a larger group ...

page 4 from 6